Bay Street Wire
Toronto & CanadaOpinion

The Cost of Caution: When Legal Battles Trump Human Lives

Portrait of Gord Mackenzie
Gord Mackenziethe columnistNov 16AI
The Cost of Caution: When Legal Battles Trump Human Lives

AI-generated image · Bay Street Wire

Ontario's medical regulator has paused new restrictions on safer supply prescriptions following a legal challenge, but the volatility of these policies leaves the city's most vulnerable in the crosshairs.

OPINION: In the sterile corridors of regulatory bodies and the hushed chambers of the courts, policy is often treated as a series of levers to be pulled. But on the streets of Toronto, those levers are the difference between a breath and a burial.

As reported by CBC Toronto, the College of Physicians and Surgeons of Ontario is hitting pause on a series of sweeping changes to how doctors prescribe safer supply drugs. This sudden halt comes after the regulator was served with a legal challenge on Friday, including a motion for an injunction. The rules, which were slated to begin on Monday, now sit in a state of limbo.

To understand why this matters, one must understand the mechanism of the proposed changes. The College of Physicians and Surgeons of Ontario sought to mandate that safer supply drugs—medications provided to those at high risk of overdose as an alternative to illicit opioids—be prescribed only in conjunction with opioid agonist therapy (OAT). OAT involves medications like methadone and Suboxone to treat addiction.

Further restricting access was a new rule requiring patients to ingest their safer supply medications under the supervision of health-care professionals instead of taking them home. While the regulator argues this is a necessary step to stop drugs from hitting the black market, it is a move that ignores the reality of human existence. As CBC Toronto notes, this requirement creates massive accessibility hurdles for those working regular hours or living in rural Ontario.

Dr. Patrick Safieh, the chair of the regulator's board, has justified these measures by citing reports from Ontario police forces that safer supply drugs are being diverted to the streets. It is a logical argument for a police officer, but a lethal one for a patient. When the state prioritizes the prevention of diversion over the prevention of death, it has failed its most basic mandate.

We are seeing a dangerous pattern where the medical regulator attempts to solve a systemic crisis with restrictive oversight. By forcing patients into supervised consumption as a condition of their prescription, the state isn't treating addiction; it is policing it.

The fact that these rules were nearly implemented—and are only paused because of a legal challenge—reveals a terrifying instability in our public health approach. We cannot treat the lives of the vulnerable as a beta test for regulatory theories. Every time the state retreats or pivots under legal pressure, it isn't just a shift in administrative strategy. For the person who cannot make it to a clinic during business hours, it is a death sentence.

Sources

More from Gord Mackenzie